nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—PGR—meningioma	0.941	1	CbGaD
Danazol—GNRHR—Hormone ligand-binding receptors—TSHB—meningioma	0.00847	0.164	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—meningioma	0.00214	0.0416	CbGpPWpGaD
Danazol—AR—FOXA1 transcription factor network—AP1B1—meningioma	0.00198	0.0384	CbGpPWpGaD
Danazol—CCL2—Ectoderm Differentiation—NF2—meningioma	0.00198	0.0383	CbGpPWpGaD
Danazol—PGR—Validated nuclear estrogen receptor alpha network—AP1B1—meningioma	0.00193	0.0374	CbGpPWpGaD
Danazol—Norelgestromin—PGR—meningioma	0.00183	0.25	CrCbGaD
Danazol—Desogestrel—PGR—meningioma	0.00176	0.241	CrCbGaD
Danazol—AR—Regulation of Androgen receptor activity—SMARCE1—meningioma	0.00171	0.0331	CbGpPWpGaD
Danazol—ESR1—FOXA1 transcription factor network—AP1B1—meningioma	0.00153	0.0296	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—meningioma	0.0015	0.0292	CbGpPWpGaD
Danazol—Etonogestrel—PGR—meningioma	0.00143	0.195	CrCbGaD
Danazol—GNRHR—GPCRs, Other—SMO—meningioma	0.00123	0.0239	CbGpPWpGaD
Danazol—AR—Nuclear Receptors—PGR—meningioma	0.00114	0.0221	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—AP1B1—meningioma	0.00113	0.0219	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—SMARCE1—meningioma	0.00113	0.0219	CbGpPWpGaD
Danazol—CYP19A1—Ovarian Infertility Genes—PGR—meningioma	0.00113	0.0218	CbGpPWpGaD
Danazol—Levonorgestrel—PGR—meningioma	0.00101	0.138	CrCbGaD
Danazol—CCL2—AP-1 transcription factor network—PLAU—meningioma	0.000903	0.0175	CbGpPWpGaD
Danazol—AR—Nuclear Receptor transcription pathway—PGR—meningioma	0.000901	0.0175	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptors—PGR—meningioma	0.000879	0.017	CbGpPWpGaD
Danazol—ESR1—Nuclear signaling by ERBB4—PGR—meningioma	0.000861	0.0167	CbGpPWpGaD
Danazol—SHBG—Nongenotropic Androgen signaling—AKT1—meningioma	0.000835	0.0162	CbGpPWpGaD
Danazol—Norethindrone—PGR—meningioma	0.000818	0.112	CrCbGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—PGR—meningioma	0.000694	0.0135	CbGpPWpGaD
Danazol—AR—Notch-mediated HES/HEY network—HES1—meningioma	0.000658	0.0128	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—TSHB—meningioma	0.000589	0.0114	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—PGR—meningioma	0.000579	0.0112	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—TSHB—meningioma	0.000539	0.0105	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—PTEN—meningioma	0.000532	0.0103	CbGpPWpGaD
Danazol—Progesterone—PGR—meningioma	0.000477	0.0651	CrCbGaD
Danazol—CCL2—TWEAK Signaling Pathway—AKT1—meningioma	0.000462	0.00895	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—TSHB—meningioma	0.000449	0.0087	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—HES1—meningioma	0.000423	0.00819	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—TSHB—meningioma	0.000411	0.00796	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—TP53—meningioma	0.000385	0.00747	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—SMO—meningioma	0.000382	0.0074	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TP53—meningioma	0.000381	0.00738	CbGpPWpGaD
Danazol—CCL2—IL-1 signaling pathway—AKT1—meningioma	0.000372	0.00721	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.000364	0.00706	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—TP53—meningioma	0.000363	0.00704	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—PLAU—meningioma	0.000351	0.0068	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—SMO—meningioma	0.000349	0.00677	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.000327	0.00634	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—AKT1—meningioma	0.000325	0.00631	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—TSHB—meningioma	0.000316	0.00612	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—PLAU—meningioma	0.000306	0.00593	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PGR—meningioma	0.00029	0.00562	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—PDGFB—meningioma	0.000289	0.0056	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.000281	0.00544	CbGpPWpGaD
Danazol—AR—Nongenotropic Androgen signaling—AKT1—meningioma	0.000259	0.00501	CbGpPWpGaD
Danazol—ESR1—Estrogen signaling pathway—AKT1—meningioma	0.000253	0.0049	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—HES1—meningioma	0.000252	0.00489	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.000252	0.00488	CbGpPWpGaD
Danazol—CYP19A1—FSH signaling pathway—AKT1—meningioma	0.000249	0.00482	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—AKT1—meningioma	0.000246	0.00478	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TP53—meningioma	0.000239	0.00464	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—TSHB—meningioma	0.000232	0.0045	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—TSHB—meningioma	0.00023	0.00447	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—meningioma	0.000214	0.00415	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—TSHB—meningioma	0.000211	0.00409	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—PLAUR—meningioma	0.000208	0.00404	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—ERBB2—meningioma	0.0002	0.00388	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—SMO—meningioma	0.000196	0.0038	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—ERBB2—meningioma	0.000194	0.00375	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—PTEN—meningioma	0.000193	0.00374	CbGpPWpGaD
Danazol—ESR1—LKB1 signaling events—TP53—meningioma	0.000182	0.00352	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—PTEN—meningioma	0.00018	0.00349	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—SMO—meningioma	0.000179	0.00347	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PDGFB—meningioma	0.00017	0.00329	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—PTEN—meningioma	0.000165	0.0032	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—meningioma	0.000159	0.00309	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—PGR—meningioma	0.000156	0.00302	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—AKT1—meningioma	0.00015	0.00292	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TSHB—meningioma	0.000136	0.00264	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—PTEN—meningioma	0.000126	0.00245	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TSHB—meningioma	0.000124	0.00241	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—meningioma	0.000123	0.00238	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000123	0.00238	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PGR—meningioma	0.00012	0.00233	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	0.00012	0.00233	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SMO—meningioma	0.000116	0.00224	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—ERBB2—meningioma	0.000114	0.0022	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—AKT1—meningioma	0.000111	0.00216	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PGR—meningioma	0.000111	0.00215	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—meningioma	0.000109	0.00211	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—AKT1—meningioma	0.000106	0.00206	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SMO—meningioma	0.000106	0.00205	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000105	0.00203	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PGR—meningioma	0.000101	0.00197	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—AKT1—meningioma	9.82e-05	0.00191	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—PTEN—meningioma	9.74e-05	0.00189	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PTEN—meningioma	9.69e-05	0.00188	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALAD—meningioma	9.55e-05	0.00185	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—AKT1—meningioma	9.51e-05	0.00184	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	9.46e-05	0.00184	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	9.24e-05	0.00179	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—meningioma	8.63e-05	0.00167	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	8.07e-05	0.00157	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSHB—meningioma	7.85e-05	0.00152	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HES1—meningioma	7.58e-05	0.00147	CbGpPWpGaD
Danazol—AR—Gene Expression—PGR—meningioma	7.5e-05	0.00145	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—meningioma	7.42e-05	0.00144	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—AKT1—meningioma	7.29e-05	0.00141	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—meningioma	7.15e-05	0.00139	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HES1—meningioma	6.94e-05	0.00135	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SMO—meningioma	6.67e-05	0.00129	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—meningioma	6.65e-05	0.00129	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PDGFB—meningioma	6.49e-05	0.00126	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—meningioma	6.27e-05	0.00122	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TSHB—meningioma	6.15e-05	0.00119	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	6.04e-05	0.00117	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PDGFB—meningioma	5.93e-05	0.00115	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PGR—meningioma	5.78e-05	0.00112	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AKT1—meningioma	5.61e-05	0.00109	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—AKT1—meningioma	5.58e-05	0.00108	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	5.51e-05	0.00107	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	4.65e-05	0.000902	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSHB—meningioma	4.61e-05	0.000893	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HES1—meningioma	4.37e-05	0.000848	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ERBB2—meningioma	4.35e-05	0.000843	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ERBB2—meningioma	3.98e-05	0.000771	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SMO—meningioma	3.92e-05	0.00076	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—meningioma	3.76e-05	0.00073	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PGR—meningioma	3.75e-05	0.000728	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PDGFB—meningioma	3.74e-05	0.000725	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—meningioma	3.71e-05	0.000719	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—meningioma	3.64e-05	0.000706	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—meningioma	3.62e-05	0.000701	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—meningioma	3.39e-05	0.000658	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—meningioma	3.31e-05	0.000641	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALAD—meningioma	2.79e-05	0.00054	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HES1—meningioma	2.57e-05	0.000498	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—meningioma	2.53e-05	0.000491	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB2—meningioma	2.51e-05	0.000486	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—meningioma	2.31e-05	0.000449	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDGFB—meningioma	2.2e-05	0.000426	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—meningioma	2.14e-05	0.000415	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—meningioma	2.14e-05	0.000414	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—meningioma	1.95e-05	0.000379	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—meningioma	1.9e-05	0.000368	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TSHB—meningioma	1.8e-05	0.000348	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—meningioma	1.68e-05	0.000325	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB2—meningioma	1.47e-05	0.000285	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—meningioma	1.46e-05	0.000283	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—meningioma	1.44e-05	0.00028	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—meningioma	1.25e-05	0.000243	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—meningioma	1.23e-05	0.000239	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—meningioma	1.11e-05	0.000216	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—meningioma	9.66e-06	0.000187	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—meningioma	8.56e-06	0.000166	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—meningioma	7.23e-06	0.00014	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—meningioma	4.89e-06	9.49e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—meningioma	2.82e-06	5.47e-05	CbGpPWpGaD
